Many people in African PrEP programmes stop and restart PrEP
On-demand PrEP is highly effective, but some may find it confusing
Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds
Uncertainties over PrEP created by NHS England's IMPACT trial "unethical"
HIV vaccine trial failure is a “wake up call” for southern Africa, say researchers
PrEP in pregnancy: safe, but many unanswered questions
Australian researchers present two possible ‘PrEP cascades’ that could be used to measure uptake
Truvada, not Descovy, should be the first choice for PrEP, US experts say
Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision
